Skip to main content
Article
New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay
Journal for ImmunoTherapy of Cancer (2015)
  • Nikoletta L Kallinteris, Peregrine Pharmaceuticals, Tustin, USA
  • Joseph Shan, Peregrine Pharmaceuticals, Tustin, USA
  • Jeffrey Meyer, University of Texas Southwestern Medical Center
  • Adam C Yopp, University of Texas Southwestern Medical Center
  • Athur Frankel, University of Texas Southwestern Medical Center
  • Sean R Downing, PerkinElmer
  • Brenda S Robertson, PerkinElmer
  • Cliff Hoyt, PerkinElmer
  • Steven King, Peregrine Pharmaceuticals, Tustin, USA
  • Carlo Bifulco, Earle A. Chiles Research Institute
  • Carmen Ballesteros-Merino, Earle A. Chiles Research Institute
  • Bernard Fox, Earle A. Chiles Research Institute
Publication Date
November 4, 2015
DOI
10.1186/2051-1426-3-S2-P94
Citation Information
Nikoletta L Kallinteris, Joseph Shan, Jeffrey Meyer, Adam C Yopp, et al.. "New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay" Journal for ImmunoTherapy of Cancer Vol. 3 Iss. 2 (2015) p. 94
Available at: http://works.bepress.com/carlo-bifulco/98/